Nakagawa K - Search Results

1

[Molecular targeted therapy in lung cancer].

Azuma K, Nakagawa K. Azuma K, et al. Among authors: nakagawa k. Nihon Rinsho. 2010 Oct;68(10):1848-53. Nihon Rinsho. 2010. PMID: 20954328 Review. Japanese.

2

[ZD1839].

Nakagawa K. Nakagawa K. Nihon Rinsho. 2002 May;60 Suppl 5:378-83. Nihon Rinsho. 2002. PMID: 12101693 Review. Japanese. No abstract available.

3

Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected].

Fukuoka M, Yano S, Giaccone G, Tamura T, Nakagawa K, Douillard JY, Nishiwaki Y, Vansteenkiste J, Kudoh S, Rischin D, Eek R, Horai T, Noda K, Takata I, Smit E, Averbuch S, Macleod A, Feyereislova A, Dong RP, Baselga J. Fukuoka M, et al. Among authors: nakagawa k. J Clin Oncol. 2003 Jun 15;21(12):2237-46. doi: 10.1200/JCO.2003.10.038. Epub 2003 May 14. J Clin Oncol. 2003. PMID: 12748244 Clinical Trial.

4

[Gefitinib in non-small cell lung cancer].

Nakagawa K. Nakagawa K. Nihon Rinsho. 2004 Jul;62(7):1312-20. Nihon Rinsho. 2004. PMID: 15283149 Review. Japanese. No abstract available.

5

Retrospective analysis of the predictive factors associated with the response and survival benefit of gefitinib in patients with advanced non-small-cell lung cancer.

Kaneda H, Tamura K, Kurata T, Uejima H, Nakagawa K, Fukuoka M. Kaneda H, et al. Among authors: nakagawa k. Lung Cancer. 2004 Nov;46(2):247-54. doi: 10.1016/j.lungcan.2004.04.032. Lung Cancer. 2004. PMID: 15474673

6

Phase I/II study of weekly docetaxel dose escalation in combination with fixed weekly cisplatin and concurrent thoracic radiotherapy in locally advanced non-small cell lung cancer.

Yamamoto N, Nishimura Y, Nakagawa K, Matsui K, Fukuoka M. Yamamoto N, et al. Among authors: nakagawa k. Cancer Chemother Pharmacol. 2006 Sep;58(3):285-91. doi: 10.1007/s00280-005-0176-3. Epub 2006 Jan 17. Cancer Chemother Pharmacol. 2006. PMID: 16416334 Clinical Trial.

7

Phase II study of weekly paclitaxel for relapsed and refractory small cell lung cancer.

Yamamoto N, Tsurutani J, Yoshimura N, Asai G, Moriyama A, Nakagawa K, Kudoh S, Takada M, Minato Y, Fukuoka M. Yamamoto N, et al. Among authors: nakagawa k. Anticancer Res. 2006 Jan-Feb;26(1B):777-81. Anticancer Res. 2006. PMID: 16739353 Free article. Clinical Trial.

8

A phase I study of irinotecan in combination with amrubicin for advanced lung cancer patients.

Kaneda H, Kurata T, Tamura K, Uejima H, Nakagawa K, Fukuoka M. Kaneda H, et al. Among authors: nakagawa k. Anticancer Res. 2006 May-Jun;26(3B):2479-85. Anticancer Res. 2006. PMID: 16821636 Free article. Clinical Trial.

9

Differential constitutive activation of the epidermal growth factor receptor in non-small cell lung cancer cells bearing EGFR gene mutation and amplification.

Okabe T, Okamoto I, Tamura K, Terashima M, Yoshida T, Satoh T, Takada M, Fukuoka M, Nakagawa K. Okabe T, et al. Among authors: nakagawa k. Cancer Res. 2007 Mar 1;67(5):2046-53. doi: 10.1158/0008-5472.CAN-06-3339. Cancer Res. 2007. PMID: 17332333

10

Is the importance of achieving stable disease different between epidermal growth factor receptor tyrosine kinase inhibitors and cytotoxic agents in the second-line setting for advanced non-small cell lung cancer?

Kurata T, Matsuo K, Takada M, Kawahara M, Tsuji M, Matsubara Y, Otani N, Matsuyama S, Muraishi K, Fujita T, Ishikawa M, Koyano K, Okamoto I, Satoh T, Tamura K, Nakagawa K, Fukuoka M. Kurata T, et al. Among authors: nakagawa k. J Thorac Oncol. 2006 Sep;1(7):684-91. J Thorac Oncol. 2006. PMID: 17409937 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,806 results

Search Page

Filters